Forte Biosciences (FBRX) Share-based Compensation (2016 - 2020)
Historic Share-based Compensation for Forte Biosciences (FBRX) over the last 5 years, with Q4 2020 value amounting to $555000.0.
- Forte Biosciences' Share-based Compensation rose 169032.26% to $555000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $956000.0, marking a year-over-year decrease of 5299.9%. This contributed to the annual value of $3.1 million for FY2024, which is 575.52% down from last year.
- According to the latest figures from Q4 2020, Forte Biosciences' Share-based Compensation is $555000.0, which was up 169032.26% from $375000.0 recorded in Q3 2020.
- Forte Biosciences' Share-based Compensation's 5-year high stood at $2.0 million during Q1 2019, with a 5-year trough of $1000.0 in Q2 2019.
- Its 5-year average for Share-based Compensation is $781700.0, with a median of $466000.0 in 2016.
- Its Share-based Compensation has fluctuated over the past 5 years, first tumbled by 9994.02% in 2019, then soared by 1865000.0% in 2020.
- Quarter analysis of 5 years shows Forte Biosciences' Share-based Compensation stood at $403000.0 in 2016, then soared by 241.19% to $1.4 million in 2017, then grew by 27.27% to $1.8 million in 2018, then crashed by 98.23% to $31000.0 in 2019, then surged by 1690.32% to $555000.0 in 2020.
- Its last three reported values are $555000.0 in Q4 2020, $375000.0 for Q3 2020, and $24000.0 during Q2 2020.